Newsroom
Sorted by: Latest
-
VENU CEO J.W. Roth Expands Capital Partner Strategy in Latest “VENU Capital Conversations” Episode
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Venu Holding Corporation ("VENU" or the "Company") (NYSE AMERICAN: VENU), an owner, operator, and developer of premium live entertainment destinations, today released Episode 3 of its investor Q&A series, VENU Capital Conversations, featuring VENU® Founder, Chairman, and CEO J.W. Roth.In the episode, Roth discusses VENU’s continued focus on non-dilutive capital and the long-term partners that will support its next projects, as Regent Bank Amphitheate...
-
Softlab360 Joins The Wealth Mosaic, Adds Strategic Partnership Exec, Earns Luminaries Recognition
NEW YORK--(BUSINESS WIRE)--Softlab360, an end-to-end software development and engineering partner for wealth management and fintech firms, today announced three milestones that broaden its role in the wealth management ecosystem. The firm has joined The Wealth Mosaic (TWM), the global wealth management solutions network, and brought on wealthtech executive Patrick Spencer, Founder and CEO, Spencer Business Strategies, LLC, to lead strategic partnership development on a fractional basis. In addit...
-
NATIXIS UK Regulatory Announcement: Form 8.3 Segro plc
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name o...
-
Hayward Holdings Reports Third Quarter Fiscal Year 2026 Financial Results and Increases 2026 Guidance
CHARLOTTE, N.C.--(BUSINESS WIRE)--Hayward Holdings, Inc. (NYSE: HAYW) (“Hayward,” the “Company,” “we,” “us,” or “our”), a leading global specialty water management company focused on designing and manufacturing pool and outdoor living technology and industrial flow control products, today announced financial results for the third quarter of fiscal year 2026, ended September 26, 2026. Comparisons are to financial results for the prior-year third fiscal quarter. CEO COMMENTS “Hayward delivered an...
-
NATIXIS UK Regulatory Announcement: Form 8.3 Prologis, Inc
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name o...
-
Tula Technology Signs Landmark Agreement Licensing Dynamic Motor Drive® to Global Tier 1 Supplier
SAN JOSE, Calif.--(BUSINESS WIRE)--Tula Technology signed a non-exclusive IP license agreement with a global Tier 1 automotive supplier covering the supplier’s entire E-drive portfolio....
-
Magnolia Oil & Gas Announces Quarterly Dividend
HOUSTON--(BUSINESS WIRE)--Magnolia Oil & Gas Announces Quarterly Dividend...
-
TCIM Issues Investor Presentation Outlining Why Voya Financial Shareholders Should Vote FOR No Confidence Referendum
NEW YORK--(BUSINESS WIRE)--TOMS Capital Investment Management (“TCIM”), which manages funds that together have an investment representing an approximately 4.65% economic interest in Voya Financial, Inc. (NYSE: VOYA) (“Voya” or the “Company”), today released an investor presentation detailing the case for shareholders to consider and vote on a non-binding resolution. This non-binding resolution allows shareholders to convey unequivocally that they “no longer continue to have confidence in the bo...
-
Latus Bio Announces the Publication of a Predictive Computational Model of Huntington’s Disease (HD) Built on Human Data Along with Validating Preclinical Data, Supporting LTS-201 as a Potential Best-in-Class, Disease-Modifying Therapy for HD
PHILADELPHIA & BOSTON--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company engineering gene therapies at scale, today announced the publication of a peer-reviewed study in Nature Communications, titled “Computational modeling and preclinical evaluation support targeting somatic instability for Huntington’s disease treatment.” The study was authored by multiple Latus scientists and led by co-corresponding authors Jang-Ho J. Cha, M.D., Ph.D. and Beverly L. Davidson, Ph.D. The public...
-
Masco Corporation Reports Third Quarter 2026 Results
LIVONIA, Mich.--(BUSINESS WIRE)--Masco Corporation (NYSE: MAS), one of the world’s leading manufacturers of branded home improvement and building products, reported its third quarter 2026 results. 2026 Third Quarter Results On a reported basis, compared to the third quarter 2025: Net sales increased 3 percent to $1,966 million; in local currency and excluding our divestiture of Bristan, net sales increased 4 percent Plumbing Products’ net sales increased 4 percent; in local currency and excludi...